2022 annual financial data
Lexicon Pharmaceuticals 2022 Net income growth
Direct answer
Net income growth was -16.16%.
Operating income was -100,760,000 USD and net income was -101,944,000 USD.
Operating cash flow was -88,851,000 USD.
Get free Lexicon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 139,000 USD
- Operating income
- -100,760,000 USD
- Net income
- -101,944,000 USD
- Operating cash flow
- -88,851,000 USD